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BACKGROUND: A synchronism exists between the respiratory and cardiac cycles. However, the influence of the inspiratory 
muscle weakness in chronic obstructive pulmonary disease (COPD) on cardiac autonomic control is unknown. The purpose of the 
present investigation was to evaluate the influence of respiratory muscle strength on autonomic control in these patients.
METHODS: Ten chronic obstructive pulmonary disease patients (69±9 years; FEV1/FVC 59±12% and FEV1 41±11% predicted) 
and nine age-matched healthy volunteers (64±5 years) participated in this study. Heart-rate variability (HRV) was obtained at rest 
and during respiratory sinusal arrhythmia maneuver (RSA-M) by electrocardiograph. 
RESULTS: Chronic obstructive pulmonary disease patients demonstrated impaired cardiac autonomic modulation at rest and 
during RSA-M when compared with healthy subjects (p<0.05). Moreover, significant and positive correlations between maximal 
inspiratory pressure (MIP) and the inspiratory-expiratory difference (∆IE) (r = 0.60, p<0.01) were found. 
CONCLUSION: Patients with chronic obstructive pulmonary disease presented impaired sympathetic-vagal balance at rest. In 
addition, cardiac autonomic control of heart rate was associated with inspiratory muscle weakness in chronic obstructive pulmo-
nary disease. Based on this evidence, future research applications of respiratory muscle training may bring to light a potentially 
valuable target for rehabilitation.
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INTRODUCTION
The maximal inspiratory pressure (MIP) generated by 
the inspiratory musculature is an index of strength that can 
be diminished in chronic obstructive pulmonary disease 
(COPD)1 and is an independent determinant of survival in 
these patient populations.2 Traditionally, inspiratory muscle 
weakness in COPD has been ascribed to factors that include 
under-perfusion,3 disuse, medication, nutritional depletion, 
systemic inflammation,4 increased resistive and elastic loads, 
and large inequalities in time constants between different 
areas of the lung.5-6 A critical factor leading to impaired 
respiratory muscle function in patients with COPD is 
pulmonary hyperinflation. The shape and geometry of the 
chest wall is altered in these patients, leading to a chronic 
reduction of the diaphragmatic apposition zone.7
Alterations of the inspiratory muscle length-tension 
relationship in patients with COPD increase the sympathetic 
vasoconstrictor activity of the cardiovascular adjustment 
center in the bulb secondary to an altered ergoreflex 
response (muscle spindles and Golgi bodies) in the 
diaphragm.7 In this context, heart-rate (HR) autonomic 
control can be assessed using HR and R-R interval indexes 
obtained during the respiratory sinus arrhythmia (RSA) 
as parasympathetic integrity markers over the sinus node. 
The RSA is characterized by the physiologic oscillations of 
HR occurring in synchronicity with the respiratory cycle.8,9 
During respiration, there is an identifiable relationship 
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between inspiration and increased in HR, caused by the 
withdrawal of vagal tone, and between expiration and 
reduced in HR, caused by increased vagal activity on 
the sinus node. An increase in the HR range during the 
respiratory cycle reflects increased cardiac health.10-11
COPD has been shown to lead to inspiratory muscle 
weakness that, in turn, could contribute to a negatively 
altered cardiovascular response during the respiratory 
cycle. Previous research has demonstrated that variations 
in the respiratory rate and tidal volume can modulate the 
magnitude of respiratory sinus arrhythmia, which is known 
as an important marker of vagal tone.10 However, it is not 
clear whether the magnitude of sinus arrhythmia is related 
to respiratory muscle weakness in COPD. 
Given this research gap, the objective of the present 
study was to evaluate the influence of respiratory muscle 
strength on the magnitude of respiratory sinus arrhythmia. 
We hypothesized that respiratory muscle weakness 
negatively influences HR variability during respiratory 
maneuvers in patients with COPD. 
METHOD
Study design and patient population
The present study was cross-sectional. The study 
population comprised 10 males with a clinical diagnosis 
of COPD according to the Global Initiative for Obstructive 
Lung Disease criteria (GOLD) and nine age- and gender-
matched sedentary control subjects. Inclusion criteria for 
COPD patients were: forced expiratory volume in one 
second (FEV1) / forced vital capacity (FVC) ratio < 0.7 
and FEV1 < 60% of predicted value; clinical stability for at 
least three months; nonsmoker status; and presentation of 
dyspnea under low and medium physical effort. All COPD 
patients used short-action bronchodilators, and six used 
long-action bronchodilators. Subjects in the control group 
were free of chronic pulmonary, cardiovascular, immune, 
and/or metabolic disease. All participants underwent a 
clinical evaluation and were screened with pulmonary 
function tests, functional capacity assessment according to 
the medical research council (MRC),13 analysis of blood 
biochemistry, electrocardiography, and symptom-limited 
exercise testing. All participants signed a written indication 
of informed consent, and the study protocol was approved 
by the University Ethics Committee. 
Experimental procedure
The volunteers were first familiarized with the 
experimental room environment and the researchers involved 
in the study. The COPD patients were instructed to avoid 
bronchodilators such as B2-agonists, xanthene derivates, 
and steroids for 24 hours before the experimental test. Prior 
to the initiation of the tests included in the present study, 
the participants were interviewed (to ensure compliance 
with medication instructions) and examined. Systolic and 
diastolic blood pressure, pulmonary auscultation, and 
peripheral oxygen saturation (SpO2) were all assessed. Only 
one data collection session was required for each subject. 
Measurements 
Pulmonary Function Test. Spirometric tests were 
performed using the Vitalograph® spirometer (Hand-Held 
2021 instrument. Ennis, Ireland). Slow vital capacity (SVC) 
and forced vital capacity (FVC) were measured to determine 
FEV1 and the FEV1/FVC ratio. Pulmonary function tests 
were performed in accordance with American Thoracic 
Society guidelines.14
Maximal Respiratory Pressures. The MIP was obtained 
from the residual volume and total lung capacity. Additionally, 
the maximal expiratory pressure was obtained from a deep 
inspiration following a maximal expiration. The subjects were 
seated, wearing nose clips and a mouthpiece. The mouthpiece 
was connected to a manual shutter apparatus, with maximal 
pressures measured by an aneroid-gauge manometer (± 300 
cmH2O) (GERAR, São Paulo, SP, Brazil). Patients were asked 
to perform maximal inspiratory and expiratory efforts against 
an obstructed mouthpiece that had a small leak to prevent 
the patients from closing their glottis during the maneuver. 
Patients sustained their maximal effort for one second. The 
best of three consecutive attempts was used to determine MIP, 
and percent-predicted values were derived.15
Heart-Rate Variability. First, the volunteers were 
maintained at rest in the supine position for approximately 
10 minutes to ensure that a true resting HR value was 
obtained. Then, the ECG signal and the instantaneous HR 
were obtained at rest in the supine position for a duration 
of 15 minutes. Subsequently, the HR and R-R intervals 
were recorded during the RSA maneuver (RSA-M) in the 
supine position in the following order: (1) for one minute 
at rest with spontaneous breathing; (2) for four minutes 
while performing the RSA-M; and (3) for one minute at 
rest with spontaneous breathing. During the RSA-M, the 
volunteers were instructed to perform a series of deep and 
slow inspirations and expirations to provide a pulmonary 
volume that varied from the total lung capacity (maximal 
inspiration) to the residual volume (maximal expiration). 
Each respiratory cycle was performed for 10 seconds, i.e., 
five seconds for inspiration and five seconds for expiration, 
which corresponds to a breathing rate of six cycles/min. 
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This breathing rate provides a maximal respiratory sinus 
arrhythmia response, according to Hayano et al.16 The 
participants controlled their breathing rate with a pointer 
clock, and, at the same time, verbal feedback was provided 
by the researcher based on observation of the visualized 
ECG signal and the HR plot on the computer monitor, which 
confirmed whether or not the respiratory cycle had been 
performed correctly. Finally, the HR and R-R intervals were 
recorded at rest in the sitting position for 15 minutes. During 
all experiments, the subjects were monitored at the CM5 
lead. The ECG signal was obtained from a one-channel heart 
monitor (TC 500, Ecafix, São Paulo, SP, Brazil) and was 
used to calculate the R-R interval using specific software.17
Heart-Rate Variability Analysis
HRV was analyzed by time and frequency domain 
methods using an algorithm developed in MatLab (version 
6.1, 450 Release 12.1). The section of highest stability, 
which included a simple line comprised of at least 256 
points, was selected from R-R intervals by visual inspection 
according to the criteria set forth by the Task Force of the 
European Society of Cardiology and the North American 
Society of Pacing and Electrophysiology.18
Time domain analysis was calculated from the RMSSD 
index [the square root of the sum of the squares of the 
differences between adjacent normal-to-normal (NN) 
intervals] and the SDNN (the standard deviation of NN 
intervals).18 Frequency domain analysis utilized the fast 
Fourier transform (FFT) of the time series. The application 
of this algorithm permitted the identification of the power 
spectral density (PSD) as well as its frequency bands: 
very low frequency (VLF), low frequency (LF), and high 
frequency (HF). Two frequency bands that best represent 
the vagal and sympathetic activity of HR control were used 
in this study. Signals in the LF band (0.04 to 0.15 Hz) have 
been predominately attributed to high sympathetic tone 
and low parasympathetic tone. On the other hand, signals 
in the HF band (0.15 to 0.4) have been attributed only 
to parasympathetic activity.18 Spectral components were 
obtained in both absolute (ms2) and normalized units (nu).18
Time and frequency analysis of the R-R intervals 
acquired during RSA-M was then performed. Additionally, 
the spectral analysis confirmed that all volunteers maintained 
a respiratory rate between five and six cycles/min, which 
corresponds to a peak spectral density frequency between 
0.08 to 0.1 Hz. Another specific routine developed in 
MatLab was used to calculate the HR and R-R interval 
indices of RSA-M,20 i.e., the expiratory/inspiratory ratio 
(E/I), which is the mean of the longest R-R interval values 
obtained during the expiratory phase divided by the mean 
of the shortest R-R interval values obtained during the 
inspiratory phase, and the inspiratory-expiratory difference 
(∆IE), which is the difference between the mean of the 
highest HR value obtained during the inspiratory phase 
and the mean of the lowest HR value obtained during the 
expiratory phase. 
Finally, the data obtained by HRV analysis in the time 
and frequency domains as well as the HR and R-R interval 
indices of RSA-M were transformed into decimal logarithms 
for statistical analysis. 
Statistical Analysis
The sample size was calculated using GraphPad StatMate 
software, version 1.01. To reach statistical significance 
(p<0.05 at a power of 90% with a confidence in terval of 
95%), a sample of nine subjects in each of the groups was 
needed to show differences in the physiologic variables 
(∆IE and SpO2). Due to the normal distribution (Shapiro-
Wilk test) and to the variance homogeneity (Levene Test) 
of the data, parametric tests were selected for statistical 
analysis. For the inter-group comparison (COPD Group vs. 
Control Group), unpaired Student’s t-test was applied. The 
Pearson correlation was used to observe the inter-variable 
relationship. All statistical analyses were carried out using 
SPSS version 10 (Chicago, IL) with the level of significance 
set at p<0.05. All data are expressed as means and standard 
deviations.
RESULTS
Subject characteristics
The subject characteristics are presented in Table 1. 
There were no differences in age, height, or body mass 
index (BMI) between the groups. However, COPD patients 
presented lower body weight when compared to the control 
group. In addition, the COPD group was classified as GOLD 
Stage IIb. Spirometric results and SpO2 values of the COPD 
group were significantly lower than those of the healthy 
individuals were. The COPD group was classified as MRC 
I (n=1), II (n=3), and III (n=6). As expected, MIP was 
significantly reduced in the COPD group in comparison to 
the control group (p<0.001).
Cardiac autonomic control at rest 
The COPD patients presented a significant reduction 
in LF in comparison to the control group (p<0.05) (Figure 
1). However, RMSSD and SDNN indices and HF did not 
present significant differences between the groups. 
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Cardiac autonomic control during RSA-M
Table 2 shows the time domain analysis of HRV during 
RSA-M. The COPD group showed lower values for the E/I 
ratio and ∆IE when compared to the control group (p<0.05). 
Additionally, lower values for the RMSSD and SDNN 
indices were observed in COPD in comparison to the control 
group. Figure 2 illustrates examples of the entire HRV power 
spectrum broken down into single spectral components from 
representative patients in the COPD and control groups. 
The representative COPD patient presented lower spectral 
components compared to the control (p<0.05). 
Relationships between maximal inspiratory pressure 
and cardiac autonomic control 
Figure 3 shows the relationship between MIP and HRV 
parameters. There was a significant positive relationship 
between MIP and the ∆IE (r = 0.60, p<0.01).
DISCUSSION
The primary findings of the present study were as 
follows: 1) COPD patients showed evidence of impaired 
Table 1 - Demographic, anthropometric, and clinical char-
acteristics for all groups.
Variables COPD (N = 10) Control (N = 9)
Demographics / Anthropometrics 
Age (yrs) 69 ± 9 64 ± 5
Height (m) 1.67 ± 0.08 1.71 ± 0.05
Weight (kg) 64 ± 9.0* 75 ± 6.3
BMI (kg/m²) 23 ± 3.3 25 ± 1.2
Spirometrics
FEV1 (% predict) 41 ± 11* 91 ± 20
FVC (% predict) 68 ± 13* 102 ± 15
FEV1/FVC 59 ± 12* 101 ± 7
Clinical characteristics 
MIP (cmH2O) 60 ± 9* 103 ± 15
MIP (% predict) 63 ± 11 99 ± 17
SpO2 (%) 92 ± 3* 96 ± 1
RF (bpm) 15 ± 4 12 ± 3
Values are means ± SD. COPD: chronic obstructive pulmonary disease; 
BMI: body mass index; EF: left ventricle ejection fraction; FEV1: forced 
expiratory volume in the first second; FEV1/FVC: forced expiratory volume 
in the first second to forced vital capacity ratio; MIP: maximal inspiratory 
pressure; SpO2: peripheral oxygen saturation; RF: respiratory frequency; * 
p<0.05: COPD vs. Control (unpaired Student’s t-test).
Figure 1 - Comparison of the heart-rate variability index obtained at rest for all groups. (A) RMSSD: the square root of the sum of the squares of differences 
between adjacent NN intervals; (B) SDNN: the standard deviation of NN intervals; (C) High frequency; and (D) Low Frequency.
373
CLINICS 2010;65(4):369-75 Deep Breathing and respiratory muscle weakness in COPD
Reis MS et al.
Copyright © 2010 CLINICS
autonomic modulation of heart rate at rest and during 
RSA-M; 2) the relationship between the MIP and HRV 
indices during RSA-M indicates that the inspiratory muscle 
weakness observed in this population may be associated with 
cardiac autonomic control.
The HRV at rest 
It has been observed in many chronic disease populations 
that the sympathetic-vagal balance of the sinus node 
is impaired, favoring sympathetic tone. In COPD, the 
coexistence of airflow limitation and the loss of the lungs’ 
elastic recoil results in modifications to the breathing pattern 
and in the volume and capacity of the lungs. For this reason, 
a series of adjustments through the interaction between the 
peripheral-central receptors and the cardiopulmonary control 
center, especially in the autonomic nervous system, occur to 
guarantee the body’s homeostasis.21
In the present study, the COPD group showed a greater 
reduction in LF values compared to the control group. 
However, the cardiac autonomic control in patients with 
COPD is unclear. Some authors22-24 have shown that these 
patients present a reduction in HRV but a predominance 
of parasympathetic activity when compared to healthy 
individuals. It is thought that accentuated vagal effects on 
cardiac autonomic control reflect vagal hyperactivity in the 
airway. On the other hand, Stewart et al.25 and Chen et al.26 
found significant sympathetic activity in COPD patients. 
The other plausible explanation in patients with COPD is 
a chemoreflexive activation of sympathetic outflow. These 
patients could present chronic hypoxemia of peripheral 
tissue, which can modify autonomic control via peripheral 
and central chemoreceptors.4,27 We speculated that these 
Table 2 - I/E ratio, IE differences, and heart-rate variabil-
ity during respiratory sinusal arrhythmia maneuver for the 
studied groups.
COPD (n = 10) Control (n = 9)
Time domain
 E/I ratio 1.1 ± 0.06 1.2 ± 0.1*
∆IE 7.0 ± 3.5 12.7 ± 4.2*
RMSSD 18.3 ± 15.6 43.5 ± 27.9*
SDNN 32.1 ± 21.2 63.8 ± 29.1*
Frequency domain
LFab 1052.7 ± 1538.3 3551.2 ± 3581.2*
HFab 93.9 ± 153.8 626.8 ± 906.8*
LFun 0.9 ± 0.03 0.8 ± 0.07
HFun 0.1 ± 0.03 0.2 ± 0.07
LF/HF 15.9 ± 15.3 11.3 ± 7.5
Values are means ± SD. COPD: chronic obstructive pulmonary disease; E/I 
ratio: expiratory/inspiratory ratio; ∆IE: inspiratory-expiratory differences; 
RMSSD: the square root of the sum of the squares of differences between 
adjacent NN intervals; SDNN: the standard deviation of NN intervals; 
LFab: low frequency in absolutes values; HFab: high frequency in absolutes 
values; LFun: low frequency in normalized units; HFun: high frequency in 
normalized units; * p<0.05: COPD vs. Control (unpaired Student’s t-test).
Figure 2 - Decomposition of the spectrum into single spectral components 
of very low frequency (VLF), low frequency (LF), and high frequency (HF) 
during the respiratory sinusal arrhythmia maneuver. (A) COPD patients; 
(B) Control group. 
Figure 3 - Pearson correlation. Correlation between MIP and inspiratory-ex-
piratory differences (I-E differences). (Legend:  = COPD and + = Control).
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autonomic control derangements in COPD patients could 
be related to the inflammatory stress and peripheral and 
respiratory muscle dysfunction present in this disease. 
The HRV during RSA-M
The HR and R-R interval indices obtained during the 
RSA-M provided relevant information concerning the vagal 
activity at the sinus node in these patients. The COPD 
patients showed a reduced parasympathetic response when 
compared to the matched control group. The results of the 
present study reaffirm previous findings demonstrating 
significant RSA-M reduction in COPD28,29 patients when 
compared to healthy volunteers. This sinus arrhythmia is 
modulated by the interaction between the cardiovascular and 
pulmonary systems. In this context, alterations in respiratory 
frequency and tidal volume can alter this relationship.7 
Because the respiratory rate was controlled during RSA-M, 
we believe that the lower RSA-M values might result from 
the reduction in tidal volume. Altered pulmonary compliance 
may be a primary mechanism for this phenomenon. As 
a result of hyperinflation, the residual volume may be 
increased in patients with COPD, thus decreasing the range 
of the tidal volume variation. Thus, although during the 
RSA-M the volunteers were instructed to perform a series of 
deep and slow inspirations and expirations, the tidal volume 
mobilized could have been minimal due to the increased 
residual volume. 
Respiratory muscle weakness and its relationship to 
cardiac autonomic control
Our evaluation of the relationships between MIP and 
RSA-M indices and between MIP and HRV indices indicated 
that subjects with respiratory muscle weakness exhibited 
a more pronounced reduction of vagal tone at the sinus 
node. Therefore, alterations of respiratory parameters can 
profoundly influence RSA-M magnitude and HRV behavior; 
slow and deep breathing will amplify RSA-M magnitude 
and HRV behavior, whereas fast and shallow breathing 
may contribute to reduced RSA-M magnitude and HRV 
behavior.7,10 Assuming that respiratory muscle weakness 
leads to shallow breathing and considering that normal 
incursion was shown to be limited by the diaphragm, the 
ergoreceptor may be activated early and may consequently 
be responsible for the fast central response in cardiac 
autonomic control.
Recent studies have shown that respiratory muscle 
strength could affect the HRV and the RSA-M magnitude 
in COPD patients with respiratory muscle weakness.30 
Therefore, this method of evaluation may be important 
for evaluating the alteration of cardiac autonomic control 
mediated by the ergoreflex in the central nervous system’s 
cardio-respiratory center, although the precise mechanism 
remains unclear. In conclusion, COPD is characterized by 
impairment of the sympathetic-vagal balance at rest. These 
alterations in cardiac autonomic control of HR are associated 
with inspiratory muscle weakness in these patients and bring 
to light a potentially valuable target for rehabilitation. 
Limitations 
The present study does possess limitations. First, 
measurement and control of the tidal volume during 
respiratory control, which was not carried out in this 
study, could have contributed to the consolidation and 
interpretation of the results found herein. Second, the 
evaluation of complete lung function (static volumes) 
would be especially relevant when evaluating these patient 
populations. These additional measurements would have 
involved the use of prohibitively expensive equipment and 
could therefore not be included. 
Clinical implications
These results could be important for identifying 
maladjustment in cardiac modulation and suggest the 
importance of rehabilitative strategies such as respiratory 
muscle training for patients with COPD who present 
significant respiratory muscle weakness. It is well 
documented that respiratory muscle training significantly 
improves pulmonary function in patients with COPD.31,32
It is presently unknown whether an improvement in 
respiratory function equates to improved cardiac autonomic 
tone in these patient populations.43 Demonstration of 
improved autonomic tone through respiratory muscle 
training would further bolster support for the implementation 
of this therapeutic intervention. Future research is required 
to clarify these issues. 
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